• Citer

Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study.

par Esteban, Emilio;Villanueva, Noemi;Muñiz, Isabel;Fernández, Yolanda;Fra, Joaquin;Luque, Maria;Jiménez, Paula;Llorente, Beatriz;Capelan, Marta ;Vieitez, José M;Estrada, Enrique;Buesa, José M;Jiménez-Lacave, Angel
Référence Investigational new drugs, 26, 1, page (67-74)
Publication Publié, 2008-02

Article révisé par les pairs

• Détails
• Contenu

Titre:	Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study.
Auteur:	Esteban, Emilio; Villanueva, Noemi; Muñiz, Isabel; Fernández, Yolanda; Fra, Joaquin; Luque, Maria; Jiménez, Paula; Llorente, Beatriz; Capelan, Marta; Vieitez, José M; Estrada, Enrique; Buesa, José M; Jiménez-Lacave, Angel
Informations sur la publication:	Investigational new drugs, 26, 1, page (67-74)
Statut de publication:	Publié, 2008-02
Sujet CREF:	Sciences bio-médicales et agricoles
	Cancérologie
MeSH keywords:	Adult
	Aged
	Anemia -- chemically induced
	Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use
	Carcinoma, Non-Small-Cell Lung -- drug therapy -- pathology
	Deoxycytidine -- administration & dosage -- adverse effects -- analogs & derivatives
	Diarrhea -- chemically induced
	Female
	Humans
	Lung Diseases -- chemically induced
	Lung Neoplasms -- drug therapy -- pathology
	Male
	Middle Aged
	Neutropenia -- chemically induced
	Prospective Studies
	Taxoids -- administration & dosage -- adverse effects
	Time Factors
	Treatment Outcome
	Vinblastine -- administration & dosage -- adverse effects -- analogs & derivatives
Note générale:	Clinical Trial, Phase II
	Journal Article
	Randomized Controlled Trial
Langue:	Anglais
Identificateurs:	urn:issn:0167-6997
	info:doi/10.1007/s10637-007-9073-4
	info:pmid/17805486